VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 187 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81,186 | -7.2% | 18,793 | +41.6% | 0.02% | -34.6% |
| Q2 2023 | $87,469 | +171.1% | 13,273 | +179.4% | 0.03% | +160.0% |
| Q1 2023 | $32,259 | -85.5% | 4,751 | -84.2% | 0.01% | -86.5% |
| Q4 2022 | $222,594 | +10.2% | 30,121 | +47.4% | 0.07% | -26.0% |
| Q3 2022 | $202,000 | +242.4% | 20,433 | +277.4% | 0.10% | +170.3% |
| Q2 2022 | $59,000 | -58.5% | 5,414 | -57.1% | 0.04% | -47.9% |
| Q1 2022 | $142,000 | -52.2% | 12,631 | -33.3% | 0.07% | -48.6% |
| Q4 2021 | $297,000 | +81.1% | 18,949 | +98.0% | 0.14% | +31.4% |
| Q3 2021 | $164,000 | -25.1% | 9,570 | -6.0% | 0.10% | -23.9% |
| Q2 2021 | $219,000 | – | 10,182 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,715,000 | $19,345,000 | 7.65% |
| Avoro Capital Advisors LLC | 2,124,593 | $23,965,000 | 6.23% |
| Asymmetry Capital Management, L.P. | 118,707 | $1,339,000 | 2.98% |
| ARMISTICE CAPITAL, LLC | 760,000 | $8,573,000 | 2.93% |
| Consonance Capital Management LP | 1,436,796 | $16,207,000 | 2.28% |
| Palo Alto Investors LP | 3,997,108 | $45,087,000 | 2.17% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,784,157 | $53,965,000 | 2.09% |
| PURA VIDA INVESTMENTS, LLC | 247,500 | $2,792,000 | 1.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,943,267 | $21,920,000 | 1.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 513,390 | $5,791,000 | 0.74% |